Pfizer (PFE): are the analysts right?

Pfizer · Health Care · ref. ETF XLV · 70 calls · price $24.07
What the company does: Pfizer découvre, développe et commercialise des produits biopharmaceutiques mondialement.
📈 1-year price
$24.07-6.0% over range
Jul 8, 25low $23.29 · high $28.55Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 12 analysts

🎯 Analyst price target on PFE

High target · 2 analysts$36+49.6%
Median target · 12 analysts$27.5+14.3%
Low target · 2 analysts$25+3.9%
Current price$24.07

🗳️ The analyst consensus

Analyst breakdown · 12 (6 months)
Strong Buy0%
Buy33%
Hold58%
Sell8%
Strong Sell0%

💰 Pfizer dividend

7.20%annual yield
That's ~$1.72 per share per year.

✅ Historical analyst reliability on PFE

Most reliable analysts on PFE (% profitable · 365j · ≥2 calls)
Guggenheim ↗ 100% +4.3% 4
Jefferies ↗ 33% -4.1% 12
Cantor Fitzgerald ↗ 0% -13.9% 12
Daiwa Capital ↗ 0% -25.3% 2

📊 What $1,000 invested in Pfizer would be worth

In short — $1,000 invested in Pfizer 10 years ago would be worth $855 today, i.e. -2%/yr on average. Best year: 2021 (+40%), worst: 2023 (-35%). Price performance, excluding dividends.

If I'd invested $1,000 in Pfizer

InvestmentWorth todayGain
1 years ago$911-9%
3 years ago$594-41%
5 years ago$719-28%
10 years ago$855-14%
since inception (1984)$15,133+1413%

Return by year (Pfizer)

YearReturn$1,000 invested at year start
2026 (YTD)-13%$871 (-13%)
2025+5%$911 (-9%)
20240%$907 (-9%)
2023-35%$594 (-41%)
2022-14%$513 (-49%)
2021+40%$719 (-28%)
2020+6%$759 (-24%)
2019-23%$585 (-41%)
2018+19%$699 (-30%)
2017+6%$744 (-26%)
2016+15%$855 (-14%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on PFE

Cantor Fitzgerald ↗
Jul 6, 26
■ Neutral neutral · not a buy · 🎯$27
Price at call : $23.72 — gap to target +14%
Today : $24.07 — gap to target +12%
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Jul 6, 27
HSBC ↗
Jul 6, 26
■ Hold neutral · not a buy · 🎯$28
Price at call : $23.72 — gap to target +18%
Today : $24.07 — gap to target +16%
🎯 on PFE : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Jul 6, 27
RBC Capital ↗
Jun 10, 26
■ Sector Perform neutral · not a buy · 🎯$25
Price at call : $26.17 — gap to target -4%
Today : $24.07 — gap to target +4%
🎯 on PFE : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jun 10, 27
Citigroup ↗
Apr 29, 26
■ Neutral neutral · not a buy · 🎯$27
Price at call : $26.7 — gap to target +1%
Today : $24.07 — gap to target +12%
🎯 on PFE : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Apr 29, 27
RBC Capital ↗
Apr 20, 26
▼ Underperform · 🎯$25
Price at call : $27.31 — upside -8%
Today : $24.07 — upside +4%
🎯 on PFE : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Apr 20, 27
CICC ↗
Apr 16, 26
▲ Outperform · 🎯$33
Price at call : $27.56 — upside +20%
Today : $24.07 — upside +37%
🎯 on PFE : no call matured yet · 📊 overall : 100% · +38.0% (7 calls)
in progress (365j)
matures : Apr 16, 27
UBS ↗
Apr 13, 26
■ Neutral neutral · not a buy · 🎯$27
Price at call : $27.11 — gap to target -0%
Today : $24.07 — gap to target +12%
🎯 on PFE : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Apr 13, 27
Morgan Stanley ↗
Apr 10, 26
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $27.34 — gap to target +2%
Today : $24.07 — gap to target +16%
🎯 on PFE : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 10, 27
B of A Securities ↗
Apr 9, 26
■ Neutral neutral · not a buy · 🎯$26
Price at call : $26.92 — gap to target -3%
Today : $24.07 — gap to target +8%
🎯 on PFE : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Apr 9, 27
Guggenheim ↗
Mar 24, 26
▲ Buy · 🎯$36
Price at call : $26.96 — upside +34%
Today : $24.07 — upside +50%
🎯 on PFE : 100% (4 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Mar 24, 27
HSBC ↗
Mar 17, 26
▲ Buy · 🎯$32
Price at call : $27.32 — upside +17%
Today : $24.07 — upside +33%
🎯 on PFE : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Mar 17, 27
Argus Research ↗
Mar 2, 26
▲ Buy · 🎯$35
Price at call : $26.58 — upside +32%
Today : $24.07 — upside +45%
🎯 on PFE : no call matured yet · 📊 on Health : 56.4% · +2.9% (156 calls)
in progress (365j)
matures : Mar 2, 27
RBC Capital ↗
Feb 25, 26
▼ Underperform · 🎯$25
Price at call : $27.1 — upside -8%
Today : $24.07 — upside +4%
🎯 on PFE : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 25, 27
Barclays ↗
Feb 20, 26
▼ Underweight · 🎯$25
Price at call : $27.06 — upside -8%
Today : $24.07 — upside +4%
🎯 on PFE : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 20, 27
Freedom Broker
Feb 9, 26
▲ Buy · 🎯$33
Price at call : $27.05 — upside +22%
Today : $24.07 — upside +37%
🎯 on PFE : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 9, 27
Cantor Fitzgerald ↗
Feb 4, 26
■ Neutral neutral · not a buy · 🎯$27
Price at call : $26.49 — gap to target +2%
Today : $24.07 — gap to target +12%
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Feb 4, 27
Cantor Fitzgerald ↗
Jan 27, 26
■ Neutral neutral · not a buy · 🎯$27
Price at call : $25.86 — gap to target +4%
Today : $24.07 — gap to target +12%
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Jan 27, 27
Morgan Stanley ↗
Dec 17, 25
■ Equal-Weight neutral · not a buy · 🎯$27
Price at call : $25.04 — gap to target +8%
Today : $24.07 — gap to target +12%
🎯 on PFE : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 17, 26
B of A Securities ↗
Dec 15, 25
■ Neutral neutral · not a buy · 🎯$28
Price at call : $26.43 — gap to target +6%
Today : $24.07 — gap to target +16%
🎯 on PFE : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Dec 15, 26
Morgan Stanley ↗
Dec 12, 25
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $26.43 — gap to target +6%
Today : $24.07 — gap to target +16%
🎯 on PFE : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 12, 26
Guggenheim ↗
Nov 24, 25
▲ Buy · 🎯$35
Price at call : $25.22 — upside +39%
Today : $24.07 — upside +45%
🎯 on PFE : 100% (4 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Nov 24, 26
Morgan Stanley ↗
Oct 10, 25
■ Equal-Weight neutral · not a buy · 🎯$32
Price at call : $24.73 — gap to target +29%
Today : $24.07 — gap to target +33%
🎯 on PFE : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Oct 10, 26
B of A Securities ↗
Oct 3, 25
■ Neutral neutral · not a buy · 🎯$30
Price at call : $27.37 — gap to target +10%
Today : $24.07 — gap to target +25%
🎯 on PFE : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Oct 3, 26
Citigroup ↗
Aug 7, 25
■ Neutral neutral · not a buy · 🎯$26
Price at call : $24.23 — gap to target +7%
Today : $24.07 — gap to target +8%
🎯 on PFE : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Aug 7, 26
Morgan Stanley ↗
Aug 6, 25
■ Equal-Weight neutral · not a buy · 🎯$33
Price at call : $24.23 — gap to target +36%
Today : $24.07 — gap to target +37%
🎯 on PFE : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Aug 6, 26
B of A Securities ↗
Aug 6, 25
■ Neutral neutral · not a buy · 🎯$28
Price at call : $23.93 — gap to target +17%
Today : $24.07 — gap to target +16%
🎯 on PFE : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Aug 6, 26
UBS ↗
Apr 30, 25
■ Neutral neutral · not a buy · 🎯$25
Price at call : $23.93 — gap to target +4%
Today : $24.07 — gap to target +4%
🎯 on PFE : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Apr 30, 26
Cantor Fitzgerald ↗
Apr 22, 25
■ Neutral neutral · not a buy · 🎯$24
Price at call : $22.53 — gap to target +7%
Today : $24.07 — gap to target -0%
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
in progress (365j)
matures : Apr 22, 26
UBS ↗
Apr 8, 25
■ Neutral neutral · not a buy · 🎯$24
Price at call : $22.49 — gap to target +7%
Today : $24.07 — gap to target -0%
🎯 on PFE : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Apr 8, 26
Goldman Sachs ↗
Apr 8, 25
■ Neutral neutral · not a buy · 🎯$25
Price at call : $22.49 — gap to target +11%
Today : $24.07 — gap to target +4%
🎯 on PFE : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Apr 8, 26
Guggenheim ↗
Mar 18, 25
▲ Buy
Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 100% (4 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+4.6%
stock +5% · XLV -0%
Guggenheim ↗
Mar 12, 25
▲ Buy
Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 100% (4 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+3.8%
stock +4% · XLV +4%
Guggenheim ↗
Feb 10, 25
▲ Buy · 🎯$33
Price at call : $25.87 — upside +28%
Today : $24.07 — upside +37%
Expected +28% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 100% (4 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+6.7%
stock +7% · XLV +6%
UBS ↗
Feb 5, 25
■ Neutral neutral · not a buy · 🎯$28
Price at call : $26.44 — gap to target +6%
Today : $24.07 — gap to target +16%
🎯 on PFE : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Feb 5, 26
Citigroup ↗
Jan 28, 25
■ Neutral neutral · not a buy · 🎯$29
Price at call : $26.75 — gap to target +8%
Today : $24.07 — gap to target +20%
🎯 on PFE : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jan 28, 26
UBS ↗
Jan 8, 25
■ Neutral neutral · not a buy · 🎯$29
Price at call : $26.72 — gap to target +9%
Today : $24.07 — gap to target +20%
🎯 on PFE : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jan 8, 26
Truist Securities ↗
Dec 18, 24
▲ Buy · 🎯$32
Price at call : $25.77 — upside +24%
Today : $24.07 — upside +33%
Expected +24% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (1 call matured) · 📊 on Health : 50% · +2.1% (248 calls)
-2.3%
stock -2% · XLV +14%
Guggenheim ↗
Dec 11, 24
▲ Buy · 🎯$33
Price at call : $25.37 — upside +30%
Today : $24.07 — upside +37%
Expected +30% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 100% (4 calls matureds) · 📊 on Health : 52.8% · +3.9% (89 calls)
+1.9%
stock +2% · XLV +9%
Wolfe Research ↗
Nov 15, 24
▼ Underperform · 🎯$25
Price at call : $24.8 — upside +1%
Today : $24.07 — upside +4%
Expected +1% · Actual +1% · Reason (≤ −15%) : ✗ No
🎯 on PFE : 0% (1 call matured) · 📊 on Health : 60.9% · +4.3% (46 calls)
-1.1%
stock +1% · XLV +7%
Morgan Stanley ↗
Oct 30, 24
■ Equal-Weight neutral · not a buy · 🎯$31
Price at call : $28.52 — gap to target +9%
Today : $24.07 — gap to target +29%
🎯 on PFE : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Oct 30, 25
Cantor Fitzgerald ↗
Oct 25, 24
▲ Overweight · 🎯$45
Price at call : $28.86 — upside +56%
Today : $24.07 — upside +87%
Expected +56% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-14.2%
stock -14% · XLV -2%
Cantor Fitzgerald ↗
Oct 23, 24
▲ Overweight · 🎯$45
Price at call : $28.64 — upside +57%
Today : $24.07 — upside +87%
Expected +57% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-13.6%
stock -14% · XLV -2%
Bernstein ↗
Oct 17, 24
■ Market Perform neutral · not a buy · 🎯$32
Price at call : $29.27 — gap to target +9%
Today : $24.07 — gap to target +33%
🎯 on PFE : no call matured yet · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : Oct 17, 25
Morgan Stanley ↗
Oct 11, 24
■ Equal-Weight neutral · not a buy · 🎯$30
Price at call : $29.16 — gap to target +3%
Today : $24.07 — gap to target +25%
🎯 on PFE : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Oct 11, 25
Cantor Fitzgerald ↗
Oct 3, 24
▲ Overweight · 🎯$45
Price at call : $28.58 — upside +57%
Today : $24.07 — upside +87%
Expected +57% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-7.5%
stock -8% · XLV -5%
Cantor Fitzgerald ↗
Sep 16, 24
▲ Overweight · 🎯$45
Price at call : $29.83 — upside +51%
Today : $24.07 — upside +87%
Expected +51% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-19.4%
stock -19% · XLV -12%
Cantor Fitzgerald ↗
Sep 9, 24
▲ Overweight · 🎯$45
Price at call : $29.74 — upside +51%
Today : $24.07 — upside +87%
Expected +51% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-17.4%
stock -17% · XLV -12%
Cantor Fitzgerald ↗
Aug 19, 24
▲ Overweight · 🎯$45
Price at call : $28.9 — upside +56%
Today : $24.07 — upside +87%
Expected +56% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-12.2%
stock -12% · XLV -11%
Daiwa Capital ↗
Aug 8, 24
▲ Outperform · 🎯$34
Price at call : $28.55 — upside +19%
Today : $24.07 — upside +41%
Expected +19% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (2 calls matureds) · 📊 on Health : 40% · -1.0% (5 calls)
-13.9%
stock -14% · XLV -13%
Barclays ↗
Jul 31, 24
■ Equal-Weight neutral · not a buy · 🎯$32
Price at call : $30.65 — gap to target +4%
Today : $24.07 — gap to target +33%
🎯 on PFE : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jul 31, 25
Cantor Fitzgerald ↗
Jul 31, 24
▲ Overweight · 🎯$45
Price at call : $30.65 — upside +47%
Today : $24.07 — upside +87%
Expected +47% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-23.4%
stock -23% · XLV -13%
Cantor Fitzgerald ↗
Jul 10, 24
▲ Overweight · 🎯$45
Price at call : $28.66 — upside +57%
Today : $24.07 — upside +87%
Expected +57% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-10.5%
stock -11% · XLV -8%
Cantor Fitzgerald ↗
Jul 1, 24
▲ Overweight · 🎯$45
Price at call : $27.83 — upside +62%
Today : $24.07 — upside +87%
Expected +62% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-9.0%
stock -9% · XLV -6%
Cantor Fitzgerald ↗
Jun 26, 24
▲ Overweight · 🎯$45
Price at call : $27.8 — upside +62%
Today : $24.07 — upside +87%
Expected +62% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-13.0%
stock -13% · XLV -8%
Cantor Fitzgerald ↗
Jun 20, 24
▲ Overweight · 🎯$45
Price at call : $27.74 — upside +62%
Today : $24.07 — upside +87%
Expected +62% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-13.4%
stock -13% · XLV -10%
Cantor Fitzgerald ↗
Jun 17, 24
▲ Overweight · 🎯$45
Price at call : $27.41 — upside +64%
Today : $24.07 — upside +87%
Expected +64% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
-12.9%
stock -13% · XLV -9%
Jefferies ↗
Oct 16, 23
▲ Buy · 🎯$39
Price at call : $33.27 — upside +17%
Today : $24.07 — upside +62%
Expected +17% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 33% (12 calls matureds) · 📊 on Health : 50.5% · +4.5% (376 calls)
-11.5%
stock -12% · XLV +17%
Daiwa Capital ↗
May 11, 23
■ Neutral neutral · not a buy · 🎯$38
Price at call : $37.58 — gap to target +1%
Today : $24.07 — gap to target +58%
🎯 on PFE : 0% (2 calls matureds) · 📊 on Health : 40% · -1.0% (5 calls)
in progress (365j)
matures : May 10, 24
Daiwa Capital ↗
Feb 7, 23
▲ Outperform · 🎯$51
Price at call : $43.59 — upside +17%
Today : $24.07 — upside +112%
Expected +17% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 0% (2 calls matureds) · 📊 on Health : 40% · -1.0% (5 calls)
-36.8%
stock -37% · XLV +9%
Jefferies ↗
Sep 13, 16
▲ Buy · 🎯$39
Price at call : $32.3 — upside +21%
Today : $24.07 — upside +62%
Expected +21% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on PFE : 33% (12 calls matureds) · 📊 on Health : 50.5% · +4.5% (376 calls)
+3.0%
stock +3% · XLV +16%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)